Have Questions?

Global Headquarters

Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157

North America

Tel: 1-617-573-9450
Fax: 1-617-573-9542

Japan

Tel: +81 (0)80-1164-4754

Request a Demo

What our customers are saying

When I think of the future, I think of EvaluatePharma

Senior Director,
Global pharmaceutical company

Unlocking the value of epidemiology data for improved portfolio decision-making

Evaluate Epi Analyzer Report 2017

Evaluate Epi Analyzer Evaluate Epi Analyzer Evaluate Epi Analyzer

Download Report

The last 5 years have witnessed a significant re-organisation of the pharmaceutical business model around the ability to identify, develop and bring to market novel therapies with proven clinical benefits in very well defined patient populations.

Our new case studies use Evaluate Epi Analyzer to highlight the value of granular patient segmentation and epidemiological data to support commercial valuations, white space identification and product differentiation.

Case Studies

  • Success in the CAR-T space – Trial population
  • Rare Disease Profiling – Determining where to play in MPS-III
  • Age-Related Macular Degeneration – Segmenting subpopulations

Evaluate Epi Analyzer brings together Evaluate's expertise in consensus forecasts with a highly granular epidemiology database.

Get unique insights on the commercial value of an indication as well as patient populations.

View brochure or request more information when you download the report.

Press Release


Confirm your details on form below to download this report